Quan Anh Vu - 08 Dec 2021 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role: COO / Chief Business Officer
Signature: /s/ Quan Anh Vu
Issuer symbol: ATNF
Transactions as of: 08 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 10 Dec 2021, 07:20:48 UTC
Previous filing: 04 Nov 2021
Next filing: 10 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ATNF	Common Stock						8,000	08 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATNF	Stock Option (Right to Buy)	Award	$0	+275,000		$0.000000	275,000	08 Dec 2021	Common Stock	275,000	$3.95	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as COO / Chief Business Officer. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.
F2	The options vest in 48 equal monthly installments, beginning on the last day of November 2021, and continuing on the last day of each calendar month thereafter, subject to the Reporting Person's continued service to the Company on such vesting dates.